Robinson MR, Leitao VA, Haleblian GE, et al.: Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation. In: J. Urol. 181. Jahrgang, Nr.3, März 2009, S.1145–1150, doi:10.1016/j.juro.2008.11.014, PMID 19152932.
europa.eu
webgate.ec.europa.eu
Eintrag zu E 332: Potassium citrates in der Europäischen Datenbank für Lebensmittelzusatzstoffe, abgerufen am 27. Juni 2020.
Sakhaee K, Nicar M, Hill K, Pak CY: Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. In: Kidney Int. 24. Jahrgang, Nr.3, September 1983, S.348–352, PMID 6645208.
Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A: Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. In: J. Urol. 158. Jahrgang, Nr.6, Dezember 1997, S.2069–2073, PMID 9366314.
Robinson MR, Leitao VA, Haleblian GE, et al.: Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation. In: J. Urol. 181. Jahrgang, Nr.3, März 2009, S.1145–1150, doi:10.1016/j.juro.2008.11.014, PMID 19152932.
Jehle S et al.: Partial neutralization of the acidogenic western diet with potassium citrate increases bone mass in postmenopausal women with osteopenia. In: J Am Soc Nephrol. (2006) 17: 3213–3222, PMID 17035614.
Marangella M et al.: Effects of potassium citrate supplementation on bone metabolism. Calcif Tissue Int (2004) 74: 330–335, PMID 15255069.
Sellmeyer DE et al.: Potassium citrate prevents increased urine calcium excretion and bone resorption induced by a high sodium chloride diet. J Clin Endocrinol Metab (2002) 87: 2008–2012, PMID 11994333.
He et al.: Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in hypertensives. In: Hypertension. (2005) Apr;45(4):571-4, PMID 15723964.
